Navigation Links
Tarix Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Study of TXA127 Following Autologous Peripheral Blood Stem Cell Transplant
Date:2/23/2011

usion of CD34+ cells. The study is expected to enroll a total of 74 patients at eight leading U.S. medical centers. For more information, please visit http://clinicaltrials.gov/ct2/show/NCT01121120?term=tarix&rank=2.

TXA127 will also be evaluated in two clinical trials in cord blood transplantation. One conducted at M D Anderson will involve adult patients, while the other at Duke University, will enroll pediatric patients.

About Tarix Pharmaceuticals

Tarix Pharmaceuticals is a clinical stage biopharmaceutical company developing peptide drugs to address significant unmet medical needs. The Company's lead product, TXA127, is a pharmaceutical formulation of the naturally occurring peptide, Angiotensin (1-7). TXA127 is currently in a Phase II clinical trial for the treatment and prevention of thrombocytopenia (reduced platelet count) associated with cancer chemotherapy, and a Phase II trial for peripheral blood stem cell engraftment. Tarix is preparing additional clinical trials with TXA127 in acute respiratory distress syndrome (ARDS), cord blood stem cell engraftment, and myelodysplastic syndrome (MDS). TXA127 is also being developed, under grants from the US government, as a treatment for radiation exposure.

Tarix's second product, PanCyte, is a synthetic, long-acting analogue of Angiotensin (1-7). PanCyte is in pre-clinical development focused on chemotherapy-induced thrombocytopenia and neutropenia, as well as combination treatment with low dose erythropoietin in chemotherapy-induced anemia.


'/>"/>
SOURCE Tarix Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Components of Extraneous Virus Detected in Rotarix Vaccine; No Known Safety Risk
2. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
3. New Data Published in The Lancet Show GSKs ROTARIX(R) Offers Protection Against the Most Common Circulating Rotavirus Types
4. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
5. Idenix Pharmaceuticals to Present at an Upcoming Investor Conference
6. Onyx Pharmaceuticals Reports Full Year and Fourth Quarter 2010 Financial Results
7. Avanir Pharmaceuticals to Present at Three Conferences in March
8. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
9. Isis Pharmaceuticals Reports That Its Selective CRP Inhibitor Demonstrated Activity in a Phase 1 Study
10. Isis Pharmaceuticals to Present at the 2011 Citi Global Healthcare Conference
11. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Calif. , June 30, 2015  Avanir ... PRISM II study showing that treatment with NUEDEXTA ... reduction in symptoms of pseudobulbar affect (PBA) in ... PBA is a distressing condition characterized by sudden ... from certain neurologic diseases or brain injury. PRISM ...
(Date:6/30/2015)... -- July 4 th is this weekend, a time we ... people behind it. To help honor our current nation,s heroes, ... Medical Card, a leading provider of free pharmacy ... independence for our disabled military veterans, police, firemen, and EMS ... prescriptions. "Due to USA ...
(Date:6/30/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/pggcjf/global_endoscopy ) ... Endoscopy Devices Market 2015-2019" report to their ... to grow at a CAGR of 5.53% over ... market can be segmented into three based on ... market can be further segments in terms of ...
Breaking Medicine Technology:Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus 2Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus 3
... that it will report its 2011 first quarter earnings on Friday, ... host an analyst and investor call at 10:00 AM EDT live ... participate in the conference call within the U.S. and Canada, dial ... dial (708) 290-1340. The conference ID is 74735682. ...
... 14, 2011 Cardinal Health today opened its first ... its nationwide capability to manufacture molecular imaging biomarkers that ... cancer, neurological disorders and heart disease. Cyclotrons ... Tomography (PET) molecular imaging agents, one of the fastest-growing ...
Cached Medicine Technology:Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 2Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 3
(Date:6/30/2015)... ... June 30, 2015 , ... After more than five years of research ... GlobalSun (TM) — sunscreen specifically formulated for the unique skin of all people of ... the market just in time to help protect the skin of all people of ...
(Date:6/30/2015)... ... June 30, 2015 , ... The United Nations Foundation’s ... Club, announced the first-ever Why We Care Youth contest today. Why We Care Youth ... access to reproductive health and contraception has personally meant to them, and why U.S. ...
(Date:6/30/2015)... PA (PRWEB) , ... June 30, 2015 , ... ... Brain Tumor Center, has joined Allegheny Health Network (AHN) as Director ... interests involve the management of primary brain tumors, brain metastases, leptomeningeal disease and ...
(Date:6/30/2015)... Angeles, California (PRWEB) , ... June 30, 2015 ... ... applauds Congressmen Joe Kennedy III (D-MA) and Danny Davis (D-IL) for writing ... speed up its investigation into the nation’s largest behavioral healthcare system, Universal Health ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... D. Wagner, Chief Research and Strategy Officer at Predictive Analytics Reporting (PAR) Framework, ... National Science Foundation (NSF), will provide keynote addresses at the 2015 STEMtech conference ...
Breaking Medicine News(10 mins):Health News:GlobalSun – The First Sunscreen Developed for All People of Color – Hits The Market 2Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 2Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 4Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 2Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 3Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 2Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 3Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 4Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 5Health News:League for Innovation Announces Distinguished Keynote Presenters for STEMtech Conference 2Health News:League for Innovation Announces Distinguished Keynote Presenters for STEMtech Conference 3
... the ensuing AIDS epidemic, a frightening group of people ... about the virus. Seth Kalichman, editor of the journal ... new book Denying AIDS, published by Springer. Denying AIDS ... the scientific and sociopolitical forces involved in AIDS denial. ...
... live close to some type of emergency room, as many ... away from the type of hospital that,s most prepared to ... a new University of Pennsylvania School of Medicine study published ... little is known about which U.S. hospitals are best equipped ...
... Church FALLS CHURCH, Va., March 17 U.S. ... and public health leaders from Virginia will hold a press ... quick passage of federal legislation that would grant the U.S. ... The House Energy and Commerce Committee passed the bill earlier ...
... 17 Herley Industries, Inc. (Nasdaq: HRLY ) ... Annual Stockholders, Meeting today at The Eden Resort Inn in ... coming. At last year,s annual shareholders meeting, I said we ... the reasonably near term. We now have a new President ...
... 17 Urban Health Plan, a network of federally ... from the Economic Stimulus Package (the American Recovery and ... in Corona, Queens. Paloma Izquierdo-Hernandez, President and CEO of ... Economic Stimulus Package funding from the federal government. The ...
... healthcare payment and clearinghouse solutions via a proprietary ... March 17 InstaMed, the industry leading healthcare ... Bala Cynwyd Pennsylvania-based venture capital firm, has joined ... growth equity financing. Ashby Point Capital of Arnold ...
Cached Medicine News:Health News:The human tragedy of denying AIDS 2Health News:1 in 4 Americans lacks timely access to optimal care during time-sensitive medical emergencies 2Health News:1 in 4 Americans lacks timely access to optimal care during time-sensitive medical emergencies 3Health News:U.S. Rep. Connolly, Inova Hospital Physicians, Public Health Groups Call for Congressional Action to Protect Kids From Tobacco 2Health News:Herley Chairman Addresses Shareholders at Annual Meeting of Shareholders March 17, 2009 2Health News:Herley Chairman Addresses Shareholders at Annual Meeting of Shareholders March 17, 2009 3Health News:Herley Chairman Addresses Shareholders at Annual Meeting of Shareholders March 17, 2009 4Health News:Urban Health Plan Receives $1.3M from Economic Stimulus Package to Increase Health Care Access in Corona, Queens 2Health News:InstaMed Announces Osage Partners and Ashby Point Capital Have Joined Existing Investors in $6 Million Growth Equity Financing 2Health News:InstaMed Announces Osage Partners and Ashby Point Capital Have Joined Existing Investors in $6 Million Growth Equity Financing 3
Replacement block for Tanne corneal punch....
... An Ultra-Fine point marker for the surgeons exacting ... to broad line marking system and a point ... their requirements. A Ruler, an optional convenience that ... or smear upon contact with liquids. The ink ...
Periosteal elevator, freer....
... The Surgifoam* absorbable gelatin sponge, U.S.P. ... gelatin absorbable sponge intended for hemostatic ... surface. The sponge is off-white and ... speed to hemostasis, highly favorable surgeon ...
Medicine Products: